- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
October 1st, 2004
To the incredibly tiny gold particles doctors send to search a blood sample for signs of illness, human cells would seem as big as mountains. But the particles' mission is to hunt down something more their size: prostate specific antigen, or PSA, a signal that prostate cancer may be on its way to returning - long before it actually does.
Welcome to the new frontier of nanotechnology, where scientists are learning how to make super-small devices - as small as genes and proteins - to diagnose diseases that remain unseen with present equipment and to provide treatments tailored to affect individual cells.
|Related News Press|
New chip makes testing for antibiotic-resistant bacteria faster, easier: Researchers at the University of Toronto design diagnostic chip to reduce testing time from days to one hour, allowing doctors to pick the right antibiotic the first time May 28th, 2015
Arrowhead to Present at Jefferies 2015 Healthcare Conference May 27th, 2015
Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies: If results are confirmed in humans, tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections; new NIH grant will fund future study May 27th, 2015
Two UCSB Professors Receive Early Career Research Awards: The Department of Energy’s award for young scientists acknowledges UC Santa Barbara’s standing as a top tier research institution May 29th, 2015